Agendia offers discovery, development, marketing, and commercialization of genomic-based diagnostic products to improve the quality of life for cancer patients by providing healthcare professionals with critical information to enable personalized treatment. It offers Symphony suite of molecular diagnostic breast cancer tests, such as TargetPrint, a microarray-based gene expression assay, which offers a quantitative assessment of the patient’s level of estrogen receptor, progesterone receptor, and HER2/neu gene within breast cancer tumor; and MammaPrint, a IVDMIA gene expression breast cancer assay that provides physicians with the ability to identify which early-stage breast cancer patients are at risk of distant recurrence following surgery.
|HQ||Irvine, CA, US||Map|
|Employees (est.) (Jan 2021)||218|
Agendia total Funding
Agendia latest funding size
Time since last funding
|9 years ago|
|ING Group, Debiopharm Group, Global Life Science Ventures, ING Corporate Investments, AXA Strategic Ventures, Gilde Healthcare, Van Herk Biotech, Breedinvest|
Agendia has 1.46k Twitter Followers. The number of followers has decreased 0.3% month over month and increased 0.7% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Agendia founded?
Agendia was founded in 2003.
Who are Agendia key executives?
Agendia's key executives are Mark R. Straley, Kurt Becker and William Audeh.
How many employees does Agendia have?
Agendia has 218 employees.
Who are Agendia competitors?
Competitors of Agendia include VERTIS Biotechnologie, CS Genetics and KBioBox.
Where is Agendia headquarters?
Agendia headquarters is located at 22 Morgan, Irvine.
Where are Agendia offices?
Agendia has offices in Irvine and Amsterdam.
How many offices does Agendia have?
Agendia has 2 offices.
Receive alerts for 300+ data fields across thousands of companies